tiprankstipranks
Advertisement
Advertisement
Chimeric Therapeutics Secures $1.62m R&D Tax Incentive Funding to Back Clinical Trials and Strategic Review
PremiumCompany AnnouncementsChimeric Therapeutics Secures $1.62m R&D Tax Incentive Funding to Back Clinical Trials and Strategic Review
1M ago
Chimeric Flags Clinical and Regulatory Risks in Forward-Looking Disclaimer
Premium
Company Announcements
Chimeric Flags Clinical and Regulatory Risks in Forward-Looking Disclaimer
1M ago
Chimeric Therapeutics Seeks ASX Quotation for 1.55m New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 1.55m New Shares
1M ago
Chimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
PremiumCompany AnnouncementsChimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
2M ago
Chimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
Premium
Company Announcements
Chimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
2M ago
Chimeric Therapeutics Seeks ASX Quotation for 733,333 New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 733,333 New Shares
3M ago
Chimeric Therapeutics Updates Capital Structure After Option Expiry
PremiumCompany AnnouncementsChimeric Therapeutics Updates Capital Structure After Option Expiry
4M ago
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
Premium
Company Announcements
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
4M ago
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
Premium
Company Announcements
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100